Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing inhaled protein therapeutics for lung diseases
Abigail Ann Matthews, Pui Lai Rachel Ee, Ruowen Ge
Molecular Biomedicine (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Discovery and Characterization of a Bicyclic Peptide (Bicycle) Binder to Thymic Stromal Lymphopoietin
Frank Narjes, Fredrik Edfeldt, Jens Petersen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2220-2235
Closed Access | Times Cited: 2
The sialidase NEU3 promotes pulmonary fibrosis in mice
Darrell Pilling, Kyle Sahlberg, Tejas R. Karhadkar, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides
Fatima Hameedat, Soraia Pinto, Joana Marques, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 6, pp. 1699-1715
Open Access | Times Cited: 5
A multi-step machine learning approach for accelerating QbD-based process development of protein spray drying
Daniela Fiedler, Elisabeth Fink, Isabella Aigner, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123133-123133
Closed Access | Times Cited: 5
Barriers for orally inhaled therapeutic antibodies
Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1071-1084
Closed Access | Times Cited: 5
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment
L Vizzoni, Chiara Migone, Brunella Grassiri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1618-1618
Open Access | Times Cited: 4
Tiny Guides, Big Impact: Focus on the Opportunities and Challenges of miR-Based Treatments for ARDS
Chirag M. Vaswani, J. V. Simone, Jacqueline L. Pavelick, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2812-2812
Open Access | Times Cited: 1
Advances in Pulmonary Protein Delivery Systems
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1
A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA’s Purple Book
Fuduan Chen, Hao Zhong, Ging Chan, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 1
In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing Omicron Subvariants
Jenny Andrea Arévalo-Romero, Gina López-Cantillo, Sara Moreno-Jiménez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10802-10802
Open Access | Times Cited: 1
Novel administration strategies for tissue-specific delivery of extracellular vesicles
Junyao Deng, Qishan Li, Fei Wang
Extracellular Vesicle (2024) Vol. 4, pp. 100057-100057
Open Access | Times Cited: 1
An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension
Vinit V. Agnihotri, Yogeeta O. Agrawal, Sameer N. Goyal, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3490-3490
Open Access | Times Cited: 7
Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins
Elimika Pfuma Fletcher, Martina Sahre, Yuen Yi Hon, et al.
The AAPS Journal (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 3
Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1
Renata Boldin, Bianca Cestari Zychar, Luís Roberto C. Gonçalves, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Influence of mesh nebulizer characteristics on aerosol delivery in non-human primates
María Cabrera, Déborah Le Pennec, Sandrine Le Guellec, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106606-106606
Open Access | Times Cited: 3
Stability Comparison Between Microglassification and Lyophilization Using a Monoclonal Antibody
Karthik Balakrishna Chandrababu, Aadithya Kannan, John R. K. Savage, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 4, pp. 1054-1060
Closed Access | Times Cited: 3
Harnessing the Potential of Enzymes as Inhaled Therapeutics in Respiratory Tract Diseases: A Review of the Literature
Gilles Vanderstocken, Nicholas L. Woolf, Giuseppe Trigiante, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1440-1440
Open Access | Times Cited: 5
Enhanced powder dispersion of dual-excipient spray-dried powder formulations of a monoclonal antibody and its fragment for local treatment of severe asthma
Harry W. Pan, Jinlin Guo, Lingqiao Zhu, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123272-123272
Open Access | Times Cited: 2
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases
Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1085-1095
Closed Access | Times Cited: 2
Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS‐CoV‐2 Variants
Jaehyeon Hwang, Beom Kyu Kim, Seokoh Moon, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 14
Closed Access
Preparation of antibody-loaded protein microbeads for pulmonary delivery via Shirasu porous glass membrane emulsification and freeze drying
Jae Chul Lee, Eun Chae Lee, Ye Na Lee, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105600-105600
Closed Access
Freezing-mediated formation of supraproteins using depletion forces
Jiankang Song, Roderick P. Tas, C. M. Martens, et al.
Journal of Colloid and Interface Science (2024) Vol. 665, pp. 622-633
Open Access
A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access
The role of airway mucus and diseased pulmonary epithelium on the absorption of inhaled antibodies
Adriana Martinez Ledo, Thomas Dimke, William R. Tschantz, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123519-123519
Closed Access | Times Cited: 1
Pulmonary Delivery of Antibody for the Treatment of Respiratory Diseases
Thomas Sécher, Nathalie Heuzé-Vourc’h
AAPS introductions in the pharmaceutical sciences (2023), pp. 21-51
Closed Access | Times Cited: 1

Scroll to top